Medical Contrast Agent Market by Type (Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, and Microbubble Contrast Media), Procedure (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound), Route of Administration (Oral Contrast Media, Injectable Contrast Media, Rectal Contrast Media, and Urethral Contrast Media), Indication (Cardiovascular Disorders, Oncology, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders), and Application (Radiology, Interventional Radiology, and Interventional Cardiology) - Global Opportunity Analysis and Industry Forecast, 2020-2027
|
A04018
|
Pages: NA
|
Jul 2020 |
2119 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Medical Contrast Agent Market
Request Now !Medical contrast agent is a material used in medical imaging to improve the contrast of structure or fluids inside a body. The contrast agents provide enhanced visibility for observation of blood vessels and the gastrointestinal tract. According to the imaging modalities such as x-ray and ultrasound, an array of contrast reagents is used as per requirement of the imaging technique.
The medical contrast agent market is driven by growth in approval of contrast agents and increase in number of private diagnostics clinics & services. Moreover, technological development in diagnostics imaging and strong product pipeline of market players are expected to boost the market growth. However, high cost of medical imaging equipment and lack of skilled professionals in the industry may impede this growth.
The global medical contrast agent market is segmented based on type, procedure, route of administration, indication, application, and region. Based on type, it is classified into barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, and microbubble contrast media. Based on procedure, it is segmented into X-ray/computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. Based on route of administration, it is categorized into oral contrast media, injectable contrast media, rectal contrast media, and urethral contrast media.
Based on indication, it is divided into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The application segment includes radiology, interventional radiology, and interventional cardiology. Based on region, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the country level to determine the market size and forecast for each segment and sub-segment.
Comprehensive competitive analysis and profiles of major players, such as GE Healthcare, Bayer AG, Bracco Imaging S.P.A., Guerbet Group, Lantheus Medical Imaging, Nanopet Pharma GmbH, CMC Contrast AB, Daiichi Sankyo, Subhra Pharma Private Limited, and Spago Nanomedical AB, are provided in this report.
Key Benefits
- The study provides an in-depth analysis, current trends, and future estimations of the global medical contrast agent market to elucidate the imminent investment pockets.
- Extensive analysis is conducted by following key player positioning and monitoring the top competitors within the market framework.
- It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
Medical Contrast Agent Market Key Segments:
By Type
- Barium-based Contrast Media
- Iodinated Contrast Media
- Gadolinium-based Contrast Media
- Microbubble Contrast Media
By Procedure
- X-ray/Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
By Route of Administration
- Oral Contrast Media
- Injectable Contrast Media
- Rectal Contrast Media
- Urethral Contrast Media
By Indication
- Cardiovascular Disorders
- Oncology
- Gastrointestinal Disorders
- Musculoskeletal Disorders
- Neurological Disorders
- Nephrological Disorders
By Application
- Radiology
- Interventional Radiology
- Interventional Cardiology
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL MEDICAL CONTRAST AGENT MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. BARIUM-BASED CONTRAST MEDIA
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. IODINATED CONTRAST MEDIA
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. GADOLINIUM-BASED CONTRAST MEDIA
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. MICROBUBBLE CONTRAST MEDIA
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 GLOBAL MEDICAL CONTRAST AGENT MARKET, BY PROCEDURE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. X-RAY/COMPUTED TOMOGRAPHY (CT)
5.2.1. Market size and forecast
5.3. MAGNETIC RESONANCE IMAGING (MRI)
5.3.1. Market size and forecast
5.4. ULTRASOUND
5.4.1. Market size and forecast
CHAPTER 6 GLOBAL MEDICAL CONTRAST AGENT MARKET, BY BY ROUTE OF ADMINISTRATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ORAL CONTRAST MEDIA
6.2.1. Market size and forecast
6.3. INJECTABLE CONTRAST MEDIAESONANCE IMAGING (MRI)
6.3.1. Market size and forecast
6.4. RECTAL CONTRAST MEDIA
6.4.1. Market size and forecast
6.5. URETHRAL CONTRAST MEDIA
6.5.1. Market size and forecast
CHAPTER 7 GLOBAL MEDICAL CONTRAST AGENT MARKET, BY INDICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. CARDIOVASCULAR DISORDERS
7.2.1. Market size and forecast
7.3. ONCOLOGY
7.3.1. Market size and forecast
7.4. GASTROINTESTINAL DISORDERS
7.4.1. Market size and forecast
7.5. MUSCULOSKELETAL DISORDERS
7.5.1. Market size and forecast
7.6. NEUROLOGICAL DISORDERS
7.6.1. Market size and forecast
7.7. NEPHROLOGICAL DISORDERS
7.7.1. Market size and forecast
CHAPTER 8 GLOBAL MEDICAL CONTRAST AGENT MARKET, BY APPLICATION
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. RADIOLOGY
8.2.1. Market size and forecast
8.3. INTERVENTIONAL RADIOLOGY
8.3.1. Market size and forecast
8.4. INTERVENTIONAL CARDIOLOGY
8.4.1. Market size and forecast
CHAPTER 9 MEDICAL CONTRAST AGENT MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. NORTH AMERICA
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.3.1. U.S. market size and forecast
9.2.3.2. Canada market size and forecast
9.2.3.3. Mexico market size and forecast
9.3. EUROPE
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.3.1. Germany market size and forecast
9.3.3.2. France market size and forecast
9.3.3.3. UK market size and forecast
9.3.3.4. Italy market size and forecast
9.3.3.5. Spain market size and forecast
9.3.3.6. Rest of Europe market size and forecast
9.4. ASIA-PACIFIC
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast
9.4.3.1. Japan market size and forecast
9.4.3.2. China market size and forecast
9.4.3.3. Australia market size and forecast
9.4.3.4. India market size and forecast
9.4.3.5. South Korea market size and forecast
9.4.3.6. Rest of Asia-Pacific market size and forecast
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.3.1. Brazil market size and forecast
9.5.3.2. Turkey market size and forecast
9.5.3.3. Saudi Arabia market size and forecast
9.5.3.4. South Africa market size and forecast
9.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 10 COMPANY PROFILES
10.1. GE HEALTHCARE
10.1.1. Operating business segments
10.1.2. Business performance
10.1.3. Key strategic moves and developments
10.2. BAYER AG
10.2.1. Operating business segments
10.2.2. Business performance
10.2.3. Key strategic moves and developments
10.3. BRACCO IMAGING S.P.A.
10.3.1. Operating business segments
10.3.2. Business performance
10.3.3. Key strategic moves and developments
10.4. GUERBET GROUP
10.4.1. Operating business segments
10.4.2. Business performance
10.4.3. Key strategic moves and developments
10.5. LANTHEUS MEDICAL IMAGING
10.5.1. Operating business segments
10.5.2. Business performance
10.5.3. Key strategic moves and developments
10.6. NANOPET PHARMA GMBH
10.6.1. Operating business segments
10.6.2. Business performance
10.6.3. Key strategic moves and developments
10.7. CMC CONTRAST AB
10.7.1. Operating business segments
10.7.2. Business performance
10.7.3. Key strategic moves and developments
10.8. DAIICHI SANKYO
10.8.1. Operating business segments
10.8.2. Business performance
10.8.3. Key strategic moves and developments
10.9. SUBHRA PHARMA PRIVATE LIMITED
10.9.1. Operating business segments
10.9.2. Business performance
10.9.3. Key strategic moves and developments
10.10. SPAGO NANOMEDICAL AB
10.10.1. Operating business segments
10.10.2. Business performance
10.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Medical Contrast Agent Market- Global Opportunity Analysis and Industry Forecast, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.